CClinicalTrials.gg
Not yet recruitingNCT07103239Updated Jan 27, 2026

Feasibility and Acceptability of Three Component Intervention for the Heart Failure Care for Rural Dwelling Participants

An interventional study of Video Based Visits and Remote Self-Care Education in Heart Failure, sponsored by University of Alabama at Birmingham. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-27.

Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research study is to determine if using remote blood pressure monitoring and video-based consultation is an effective way to help patients in rural communities better manage their heart failure.

02

Conditions studied

  • Heart Failure

Browse trials for

03

In context

Heart Failure

5,697 studies on the registry are indexed under Heart Failure; 1,219 are open to participants now.

This study's planned enrollment of 32 is below the median of 72 across 3,733 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.

Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnosis of Heart Failure
  • English speaking
  • primary residence in counties of interest

Exclusion criteria

Exclusion Criteria:

  • N/A
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Video Based Visits

    Patients assigned to remote consultation will receive a video-based visit with the HF care team using the software platform of the PI's eMedicine division

    Behavioral: Video Based Visits

  • Experimental
    Remote Self-Care Education

    The intervention will be regular training at designated intervals vs self-guided education

    Behavioral: Remote Self-Care Education

  • Experimental
    Remote Patient Monitoring

    The devices include a mobile device, blood pressure cuff, and digital scale. The Remote Patient Monitoring team will call the consented participant over the phone to help with setup and use of the devices

    Behavioral: Remote Patient Monitoring

Interventions

  • BehavioralVideo Based Visits

    Video based visit with Heart Failure team

  • BehavioralRemote Self-Care Education

    Self Guided Training

  • BehavioralRemote Patient Monitoring

    Participant will use home devices to monitor blood pressure and weight; Participant will then send results to RN educator

06

What researchers measure

Primary outcomes

  1. Feasibility

    Feasibility will be measured by recruitment rates (number screened vs. number enrolled), retention rates (percentage of participants that complete study), and participation metrics. We will aim to enroll at least 40% of the patients we approach for recruitment, and complete follow-up in at least 80% of all enrolled subjects.

    Time frame: 3 months

07

Study locations

1 site
  • University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
    • Stephen Clarkson, MD · Contact · sclarkso@uab.edu · 1-855-860-3789
    • Stephen Clarkson, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07103239
Lead sponsor
University of Alabama at Birmingham
Collaborators
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Stephen Clarkson (Principal Investigator, University of Alabama at Birmingham) — Principal investigator
First posted
Aug 5, 2025
Start date
Jan 2027 (estimated)
Primary completion
Jan 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jan 27, 2026

Study contacts

Stephen Clarkson, MD
Contact
sclarkso@uab.edu
205-975-7123

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion